glp 1 agonist or antagonist A Closer Look at the Dermatological Profile of GLP-1 Agonists The Premise of the Paradox:
Description
Hoosein NM, Gurd RS
The author declares that there is no conflict of interest
In trials, ~3045% of patients experienced nausea, especially initially ( [104] )
The appetite suppression, metabolic changes, and gut hormone modulation provided by tirzepatide reverse when the medication is discontinued
